{
  "ptid_time": "011_S_4222_2011-09-14",
  "img_path": "/data/qiuhui/data/adni/images/011_S_4222/2011-09-14/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 57,288 mm³, 55.0% above the reference mean. With a Z-score of 1.48 (93.1th percentile), this represents mild enlargement; hippocampal volume measures 5,160 mm³, 20.6% below the reference mean. With a Z-score of -1.65 (5.0th percentile), this represents moderate atrophy; whole brain volume measures 950,071 mm³, 2.4% above the reference mean. With a Z-score of 0.28 (61.1th percentile), this represents normal volume ; entorhinal cortex volume measures 2,372 mm³, 31.5% below the reference mean. With a Z-score of -1.70 (4.5th percentile), this represents moderate atrophy; fusiform gyrus volume measures 16,399 mm³, 1.8% above the reference mean. With a Z-score of 0.13 (55.4th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,630 mm³, 8.9% above the reference mean. With a Z-score of 0.79 (78.5th percentile), this represents normal volume . ",
  "text_data": "Age is 82.3 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking; Major Surgical Procedures. MMSE: 30.0. MoCA: 24.0. Logical Memory: 10.0. Laboratory findings: Triglycerides (GPO): 238.00 (significant elevated); GGT: 65.00 (profound elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.00 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows moderate atrophy in the hippocampus and entorhinal cortex, which are key regions affected in Alzheimer's disease (AD). However, cognitive scores (MMSE 30, MoCA 24) are borderline for mild cognitive impairment (MCI), with no clear functional decline reported. The presence of one APOE4 allele and normal AV45 (amyloid PET) complicates the picture, as amyloid burden is not confirmed.  \n\n**Diagnosis:** **MCI** (given cognitive scores and hippocampal/entorhinal atrophy, but lack of clear dementia-level impairment or amyloid confirmation).  \n\n**Confidence:** **Medium** (atrophy patterns suggest neurodegeneration, but normal amyloid and high MMSE introduce uncertainty about progression to dementia).  \n\n*Note: A follow-up clinical assessment focusing on daily functioning and repeat cognitive testing would help clarify progression.*",
  "timestamp": "2025-07-25T22:55:15.357102"
}